BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22242853)

  • 1. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse agonists and antagonists of retinoid receptors.
    Bourguet W; de Lera AR; Gronemeyer H
    Methods Enzymol; 2010; 485():161-95. PubMed ID: 21050917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications for ligands of retinoid receptors.
    Thacher SM; Vasudevan J; Chandraratna RA
    Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
    Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.
    Gericke J; Ittensohn J; Mihály J; Alvarez S; Alvarez R; Töröcsik D; de Lera AR; Rühl R
    PLoS One; 2013; 8(4):e62643. PubMed ID: 23638129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
    Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
    Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor modulators: a perspective on recent advances and promises.
    Alvarez S; Bourguet W; Gronemeyer H; de Lera AR
    Expert Opin Ther Pat; 2011 Jan; 21(1):55-63. PubMed ID: 21091043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.
    le Maire A; Teyssier C; Balaguer P; Bourguet W; Germain P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid receptors: structural basis for coregulator interaction and exchange.
    le Maire A; Bourguet W
    Subcell Biochem; 2014; 70():37-54. PubMed ID: 24962880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
    Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
    Makishima M; Shudo K; Honma Y
    Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors.
    Busby SA; Kumar N; Kuruvilla DS; Istrate MA; Conkright JJ; Wang Y; Kamenecka TM; Cameron MD; Roush WR; Burris TP; Griffin PR
    ACS Chem Biol; 2011 Jun; 6(6):618-27. PubMed ID: 21381756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.